Back
Ultragenyx Pharmaceutical Vs. Atlassian Industry Stock Comparison
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
51.12
Seasonality Move:
11.73%
Buy
77
TEAM
Atlassian
Last Price:
219.05
Seasonality Move:
10.66%
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $50.99. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Atlassian (TEAM)
is a Buy
Is Atlassian a Buy, Sell or Hold?
- The current Atlassian [TEAM] share price is $224.35. The Score for TEAM is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- TEAM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $50.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
TEAM Stock Price Chart
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.96 | Sell |
| Relative Strength Index (14 RSI): | 32.54 | Sell |
| Chaikin Money Flow: | -444600 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.55 - 56.01) | Sell |
| Bollinger Bands (100): | (43.86 - 56.78) | Buy |
TEAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.65 | Buy |
| Relative Strength Index (14 RSI): | 81.32 | Buy |
| Chaikin Money Flow: | 3213055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (167.26 - 197.54) | Buy |
| Bollinger Bands (100): | (153.87 - 183.99) | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.87 | Sell |
| 20-day SMA: | 54.07 | Sell |
| 50-day SMA: | 55.69 | Sell |
| 200-day SMA: | 47.79 | Buy |
| 8-day EMA: | 52.55 | Sell |
| 20-day EMA: | 53.85 | Sell |
| 50-day EMA: | 53.79 | Sell |
| 200-day EMA: | 48.79 | Buy |
TEAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 193.81 | Buy |
| 20-day SMA: | 187.89 | Buy |
| 50-day SMA: | 172.54 | Buy |
| 200-day SMA: | 183.8 | Buy |
| 8-day EMA: | 197.13 | Buy |
| 20-day EMA: | 188.17 | Buy |
| 50-day EMA: | 177.53 | Buy |
| 200-day EMA: | 178.95 | Buy |
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.
Atlassian Earnings Growth & TEAM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.10 per share, and an increase next year of $0.40 per share.
Ultragenyx Pharmaceutical Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Atlassian Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||